Akums Drugs and Pharmaceuticals
Signals mentioning Akums Drugs and Pharmaceuticals
- Oriflame targets India at 25% of global revenue by 2030
- Oriflame resists quick commerce, targets 1 million India partners by 2030
- Oriflame doubles down on direct selling, targets 1 million India partners by 2030
- Oriflame to transfer India manufacturing operations to Akums subsidiary
- Milky Mist eyes ₹1,553 crore IPO launch by mid-August after ₹482 crore pre-IPO raise
- Akums to buy Oriflame India’s manufacturing business for Rs 56 crore
- Akums to acquire Oriflame India’s manufacturing assets for Rs 56 crore